SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898432-07-000718
Filing Date
2007-08-13
Accepted
2007-08-13 15:22:31
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS, L.P.INVESTMENTS 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 bvf-cypress_13g.htm SC 13G 94720
2 EXHIBIT 1 exhibit_99.htm EX-99 12944
  Complete submission text file 0000898432-07-000718.txt   110037
Mailing Address 4350 EXECUTIVE DRIVE,SUITE 325 SAN DIEGO CA 92121
Business Address 4350 EXECUTIVE DRIVE,SUITE 325 SAN DIEGO CA 92121 8584522323
CYPRESS BIOSCIENCE INC (Subject) CIK: 0000716054 (see all company filings)

IRS No.: 222389839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-35589 | Film No.: 071048788
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice